Viewing Study NCT06523634



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06523634
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-05-28

Brief Title: Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy
Sponsor: None
Organization: None

Study Overview

Official Title: Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: STEREOBED
Brief Summary: This is a a randomized phase IIIII trial comparing salvage SBRT with standard of care SOC regimens for patients with a persistent detectable PSA or biochemical progression during follow-up after radical prostatectomy
Detailed Description: This is a multicentric randomized seamless phase IIIII study comparing SBRT to conventional RT or moderately hypofractionated RT on the prostate bed

All subjects will be randomly assigned in a 11 ratio

1 Experimental arm Radiotherapy treatment of prostate bed in 5 fractions
2 Control arm Radiotherapy treatment of prostate bed within a normofractionated or mildly hypofractionated schedule For the control arm each participating center can choose between a normofractionated schedule 32 to 35 treatment sessions and a moderately hypofractionated schedule 20 sessions

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None